← Leaderboards
David E Wentworth
University Of Colorado Denver
$5,498,331
Attributed
$5,498,331
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–14$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$5,498,331 · 3
By mechanism
U19$2,928,918 · 1
P01$1,982,711 · 1
R21$586,702 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Thomas E Morrison$8,729,587
- Gregory B Melikian$34,154,187
- Robert Turner Schooley$73,100,957
- Kathryn V Holmes$8,438,832
- Dirk Homann$7,889,596
Others in their field
Top investigators on “Antiviral Agents”
- Constance Ann Benson · University Of California, San Diego$209,152,068
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$120,325,769
- Judith S. Currier · University Of California Los Angeles$102,391,456
- Beth Baseler · Leidos Biomedical Research, Inc.$83,440,795
- Sharon A Nachman · Johns Hopkins University$77,262,665
- John Damon Chodera · Sloan-Kettering Inst Can Research$58,660,403
Research focus
Antiviral AgentsImmune ResponseGlycoproteinsSevere Acute Respiratory SyndromeReceptor ExpressionAnimalsPandemic DiseaseImmunocytochemistryPathogenResponseVirusViralPathogenesisEpidemicVaccinesGenomeDisease OutbreaksChickensCellsAntibodiesCanis FamiliarisDesignAnimal Disease ModelsFamily Suidae
Grant awards (8)
Exploiting Viral Genomics to Understand Disease$2,928,918
U19 · FY2014 · AI · contact PI
Generation of a Transgenic Model for SARS-CoV$397,780
P01 · FY2008 · AI · contact PI
Generation of a Transgenic Model for SARS-CoV$391,989
P01 · FY2007 · AI · contact PI
Generation of a Transgenic Model for SARS-CoV$401,994
P01 · FY2006 · AI · contact PI
Generation of a Transgenic Model for SARS-CoV$381,789
P01 · FY2005 · AI
Discovery of a Novel Promoter in Pathogenic Influenza$297,205
R21 · FY2005 · AI
Generation of a Transgenic Model for SARS-CoV$409,159
P01 · FY2004 · AI
Discovery of a Novel Promoter in Pathogenic Influenza$289,497
R21 · FY2004 · AI